← Eichor
Study identifier: NCT05100992 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Progress Bifurcation Global Registry

Condition: Coronary Artery Disease · Coronary Bifurcation Lesions  ·  Sponsor: Minneapolis Heart Institute Foundation

PhaseN/A
Planned participants4000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Coronary bifurcation lesions are lesions (or blockages) that occur at or near the intersection of a major coronary artery and one of the arteries' side branches. Numerous techniques and devices have been developed to treat coronary bifurcations; however, these types of lesions remain some of the most challenging, both in terms of procedural success and outcome. This study is designed as an observational, multi-center registry that will collect information on treatment strategies and outcomes of consecutive patients undergoing percutaneous coronary interventions (PCI) in coronary bifurcations among various participating centers, in order to determine the frequency of bifurcation PCI, the procedural strategies utilized, and the procedural outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

Emmanouil Brilakis, MD, PhD  ·  612-863-3852  ·  emmanouil.brilakis@allina.com

Bavana Rangan, BDS, MPH  ·  612-863-3852  ·  bavana.rangan@allina.com

Always discuss trial participation with your own doctor first.

Locations (1)

Minneapolis Heart Institute FoundationMinneapolis, Minnesota, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05100992